Lamprene Capsule, Liquid Filled
Product Images NDC 0078-1049

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lamprene (NDC 0078-1049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Lamprene. (Lamprene 01)

Chemical structure of Clofazimine, the active ingredient in Lamprene 50 mg capsules. The diagram shows the molecular arrangement including aromatic rings, nitrogen atoms, chlorine substituents, and methyl groups.*

FDA Label Image

Principal Display Panel Ndc 0078-1049-05 Rx Only Lamprene® (clofazimine) Capsules 50 mg For Oral Use 100 Capsules Novartis (Lamprene 02)

Lamprene 50 mg capsules label by Novartis Pharmaceuticals Corporation. It is an oral, liquid-filled capsule prescription drug with a package size of 100 capsules. The label includes dosing and prescribing information and the NDC number 0078-1049-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.